A series of thiadiazolo[3,4- c ]pyridine-cored organic sensitizers has been prepared for DSSC applications. The structural optimization with π-conjugated spacers enhanced the power conversion efficiency to 6.30% from 2.86%.
No takes yet. Share an insight, caveat, or question.
Hua et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: